CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C17704 | BRD-K47903820 | BRD-K47903820 | -- | -- | -- | Details |
| C17705 | BRD-K47904921 | BRD-K47904921 | -- | -- | -- | Details |
| C17706 | BRD-K47906308 | BRD-K47906308 | -- | -- | -- | Details |
| C17707 | BRD-K47906330 | BRD-K47906330 | -- | -- | -- | Details |
| C17708 | BRD-K47917680 | BRD-K47917680 | -- | -- | -- | Details |
| C17709 | BRD-K47924474 | BRD-K47924474 | -- | -- | -- | Details |
| C17710 | BRD-K47926785 | BRD-K47926785 | -- | -- | -- | Details |
| C17711 | BRD-K47926873 | BRD-K47926873 | -- | -- | -- | Details |
| C17712 | BRD-K47929404 | vercirnon | -- | -- | -- | Details |
| C17713 | BRD-K47936004 | piribedil | ADRA2A; DRD2; DRD3 | Dopamine receptor agonist | -- | Details |
| C17714 | BRD-K47943470 | tyrphostin-51 | -- | -- | TYRPHOSTIN-51 | Details |
| C17715 | BRD-K47943934 | BRD-K47943934 | -- | -- | -- | Details |
| C17716 | BRD-K47947160 | BRD-K47947160 | -- | -- | -- | Details |
| C17717 | BRD-K47950966 | BRD-K47950966 | -- | -- | -- | Details |
| C17718 | BRD-K47951404 | BRD-K47951404 | -- | -- | -- | Details |
| C17719 | BRD-K47951859 | BRD-K47951859 | -- | -- | -- | Details |
| C17720 | BRD-K47962810 | BRD-K47962810 | -- | -- | -- | Details |
| C17721 | BRD-K47966145 | BRD-K47966145 | -- | -- | -- | Details |
| C17722 | BRD-K47967838 | BRD-K47967838 | -- | -- | -- | Details |
| C17723 | BRD-K47971885 | BRD-K47971885 | -- | -- | -- | Details |
| C17724 | BRD-K47976015 | balapiravir | -- | -- | -- | Details |
| C17725 | BRD-K47977047 | BRD-K47977047 | -- | -- | -- | Details |
| C17726 | BRD-K47980183 | BRD-K47980183 | -- | -- | -- | Details |
| C17727 | BRD-K47981327 | SR-1001 | -- | -- | -- | Details |
| C17728 | BRD-K47983010 | BX-795 | PDK1; PDPK1 | IKK inhibitor | -- | Details |
| C17729 | BRD-K47984776 | BRD-K47984776 | -- | -- | -- | Details |
| C17730 | BRD-K47988839 | BRD-K47988839 | -- | -- | -- | Details |
| C17731 | BRD-K47991733 | BRD-K47991733 | -- | -- | -- | Details |
| C17732 | BRD-K47992037 | BRD-K47992037 | -- | -- | -- | Details |
| C17733 | BRD-K47994485 | BRD-K47994485 | -- | -- | -- | Details |
| C17734 | BRD-K47995281 | BRD-K47995281 | -- | -- | -- | Details |
| C17735 | BRD-K47995524 | BRD-K47995524 | -- | -- | -- | Details |
| C17736 | BRD-K47998973 | BRD-K47998973 | -- | -- | -- | Details |
| C17737 | BRD-K47999752 | BRD-K47999752 | -- | -- | -- | Details |
| C17738 | BRD-K48001367 | BRD-K48001367 | -- | -- | -- | Details |
| C17739 | BRD-K48005659 | BRD-K48005659 | -- | -- | -- | Details |
| C17740 | BRD-K48005755 | BRD-K48005755 | -- | -- | -- | Details |
| C17741 | BRD-K48006774 | BG-1004 | -- | -- | -- | Details |
| C17742 | BRD-K48012250 | BRD-K48012250 | -- | -- | -- | Details |
| C17743 | BRD-K48016779 | BRD-K48016779 | -- | -- | -- | Details |
| C17744 | BRD-K48018815 | BRD-K48018815 | -- | -- | -- | Details |
| C17745 | BRD-K48019220 | BRD-K48019220 | -- | -- | -- | Details |
| C17746 | BRD-K48020855 | BRD-K48020855 | -- | -- | -- | Details |
| C17747 | BRD-K48023456 | BRD-K48023456 | -- | -- | -- | Details |
| C17748 | BRD-K48029682 | BRD-K48029682 | -- | -- | -- | Details |
| C17749 | BRD-K48029790 | OBAA | PLA2G1B | Phospholipase inhibitor | -- | Details |
| C17750 | BRD-K48030215 | BRD-K48030215 | -- | -- | -- | Details |
| C17751 | BRD-K48031880 | BRD-K48031880 | -- | -- | -- | Details |
| C17752 | BRD-K48035058 | BRD-K48035058 | -- | -- | -- | Details |
| C17753 | BRD-K48035513 | BRD-K48035513 | -- | -- | -- | Details |
| C17754 | BRD-K48036219 | BRD-K48036219 | -- | -- | -- | Details |
| C17755 | BRD-K48038858 | BRD-K48038858 | -- | -- | -- | Details |
| C17756 | BRD-K48040318 | BRD-K48040318 | -- | -- | -- | Details |
| C17757 | BRD-K48046422 | BRD-K48046422 | -- | -- | -- | Details |
| C17758 | BRD-K48047626 | BRD-K48047626 | -- | -- | -- | Details |
| C17759 | BRD-K48047846 | BRD-K48047846 | -- | -- | -- | Details |
| C17760 | BRD-K48050202 | BRD-K48050202 | -- | -- | -- | Details |
| C17761 | BRD-K48052543 | BRD-K48052543 | -- | -- | -- | Details |
| C17762 | BRD-K48052985 | BRD-K48052985 | -- | -- | -- | Details |
| C17763 | BRD-K48053776 | BRD-K48053776 | -- | -- | -- | Details |
| C17764 | BRD-K48054407 | BRD-K48054407 | -- | -- | -- | Details |
| C17765 | BRD-K48056188 | BRD-K48056188 | -- | -- | -- | Details |
| C17766 | BRD-K48058738 | BRD-K48058738 | -- | -- | -- | Details |
| C17767 | BRD-K48059230 | YM-298198 | GRM1 | Glutamate receptor antagonist | -- | Details |
| C17768 | BRD-K48059443 | BRD-K48059443 | -- | -- | -- | Details |
| C17769 | BRD-K48062199 | GSK-2801 | -- | -- | -- | Details |
| C17770 | BRD-K48066866 | BRD-K48066866 | -- | -- | -- | Details |
| C17771 | BRD-K48068743 | teneligliptin | DPP4 | Dipeptidyl peptidase inhibitor | -- | Details |
| C17772 | BRD-K48069820 | BRD-K48069820 | -- | -- | -- | Details |
| C17773 | BRD-K48076585 | BRD-K48076585 | -- | -- | -- | Details |
| C17774 | BRD-K48089931 | BRD-K48089931 | -- | -- | -- | Details |
| C17775 | BRD-K48092898 | BRD-K48092898 | -- | -- | -- | Details |
| C17776 | BRD-K48097043 | BRD-K48097043 | -- | -- | -- | Details |
| C17777 | BRD-K48099440 | BRD-K48099440 | -- | -- | prostaglandin-e1 | Details |
| C17778 | BRD-K48101260 | BRD-K48101260 | -- | -- | -- | Details |
| C17779 | BRD-K48102350 | BRD-K48102350 | -- | -- | -- | Details |
| C17780 | BRD-K48102470 | BRD-K48102470 | -- | -- | -- | Details |
| C17781 | BRD-K48105325 | BRD-K48105325 | -- | -- | -- | Details |
| C17782 | BRD-K48112880 | FH-535 | -- | -- | -- | Details |
| C17783 | BRD-K48113109 | BRD-K48113109 | -- | -- | -- | Details |
| C17784 | BRD-K48113764 | BRD-K48113764 | -- | -- | -- | Details |
| C17785 | BRD-K48114548 | BRD-K48114548 | -- | -- | -- | Details |
| C17786 | BRD-K48115423 | BRD-K48115423 | -- | -- | 2-(4-methoxybenzylthio)-6-methylpyrimidin-4-ol | Details |
| C17787 | BRD-K48116811 | BRD-K48116811 | -- | -- | -- | Details |
| C17788 | BRD-K48129913 | BRD-K48129913 | -- | -- | -- | Details |
| C17789 | BRD-K48138407 | BRD-K48138407 | -- | -- | -- | Details |
| C17790 | BRD-K48140215 | BRD-K48140215 | -- | -- | -- | Details |
| C17791 | BRD-K48141473 | cebranopadol | OPRL1; OPRM1 | Opioid receptor agonist | -- | Details |
| C17792 | BRD-K48143921 | BRD-K48143921 | -- | -- | -- | Details |
| C17793 | BRD-K48145537 | BRD-K48145537 | -- | -- | -- | Details |
| C17794 | BRD-K48147099 | BRD-K48147099 | -- | -- | -- | Details |
| C17795 | BRD-K48150994 | BRD-K48150994 | -- | -- | -- | Details |
| C17796 | BRD-K48165980 | BRD-K48165980 | -- | -- | -- | Details |
| C17797 | BRD-K48168960 | propylthiouracil | DIO1; TPO | Thyroid peroxidase inhibitor | -- | Details |
| C17798 | BRD-K48171978 | BRD-K48171978 | -- | -- | -- | Details |
| C17799 | BRD-K48178389 | BRD-K48178389 | -- | -- | -- | Details |
| C17800 | BRD-K48180773 | BRD-K48180773 | -- | -- | -- | Details |
| C17801 | BRD-K48182764 | SL-0101-1 | -- | -- | -- | Details |
| C17802 | BRD-K48183516 | BRD-K48183516 | -- | -- | -- | Details |
| C17803 | BRD-K48188521 | BRD-K48188521 | -- | -- | -- | Details |